What nanoTherics does

nanoTherics is a privately-held for-profit company founded in 2007 and headquartered in Stoke-on-Trent, United Kingdom. The firm develops and supplies IP-protected instrumentation products that support research and applied work in the field of magnetic nanoparticles, a specialized segment of the scientific instruments market. Its customer base is implicitly research-oriented, serving academic, government, and industrial laboratories engaged in nanoparticle research and applications development.

The company's product portfolio centers on hardware and supporting IP for magnetic nanoparticle manipulation and characterization, a niche where specialist technical expertise is required. Its leadership team includes a founder with research credentials (Jon Dobson), a CEO (Carlton Jones), a Chairman (Jeremy Warren), and operational leadership (Neil Farrow as Director/COO, Mark Payton as Director), suggesting a lean management structure appropriate for a small specialist firm. The firm operates with 11-50 employees.

Revenue mechanics are not disclosed in the available source material, and no pricing model, distribution channel, or customer-segment data is publicly available. The company has raised approximately $1.74M from Catapult Ventures and Mercia Fund Managers (2010) and received earlier investment from WM Enterprise Investment Division (2008), with no subsequent funding rounds disclosed. The company's own website content was unavailable at the time of data collection (displayed a verification/loading page), limiting granular visibility into product specs, customer mix, and commercial performance.

Name

nanoTherics

Website

https://nanotherics.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

nanoTherics is a UK-based specialist instrumentation company founded in 2007 that supplies IP-protected products supporting magnetic nanoparticle research and applications for scientific and laboratory customers.

Ownership category

akta.pro rank

Product category

Life Science Research Instruments

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Research and Development in Nanotechnology (541713)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Non-viral Gene Delivery & Gene Therapy (LNP, polymers, electroporation, physical methods) (HLAAACAC)

akta.pro secondary industry

Magnetic Field Control & Shielding (Coils, Mu-Metal, Active Cancellation) (HDAGABAK)

Keywords

• Magnetic nanoparticle research
• Magnetic cell transfection
• Life science instruments
• Nanoparticle transfection systems
• Lab research equipment

Headquarters

HQ city

Stoke-on-trent

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Core offering

nanoTherics offers IP-protected products that support the field of magnetic nanoparticle research and applications. The company's portfolio centers on instruments and consumables used for magnetic cell transfection and related nanomaterial research workflows, primarily serving life science research laboratories.

Differentiator

Problem solved

Functional benefit

Products and services

• IP-protected magnetic nanoparticle research products Hardware instruments and consumables used by life science researchers to perform magnetic cell transfection and study magnetic nanoparticle applications.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves2 records

Direct peers

• OZ Biosciences: French developer of magnetofection reagents and the PolyMag/PromoMag transfection platforms. Directly comparable to nanoTherics as both sell magnetic-nanoparticle-based transfection systems to the same academic and cell-therapy research customers.
• Chemicell: Berlin-based manufacturer of magnetic nanoparticles and magnetofection consumables (e.g., TransMAG). Competes head-to-head with nanoTherics in supplying researchers with magnetic particles and protocols for transfection and cell separation.
• MaxCyte: Public US company specializing in electroporation-based transfection (Flowfect/ExPERT) for cell and gene therapy manufacturing. A substitute technology to magnetofection serving the same customer base, and the most direct alternative nanoTherics customers evaluate.
• BTX (Harvard Bioscience): Provider of electroporation and nucleofection instruments for transfection. Competes with nanoTherics for the same transfection budget at research and process-development labs.

Broad incumbents

• Miltenyi Biotec: Large, established life-science tools provider offering cell-separation, transfection, and cell-therapy manufacturing solutions. A broad incumbent whose portfolio overlaps with nanoTherics' niche in non-viral cell engineering and magnetic-bead workflows.
• Thermo Fisher Scientific: Global life-science tools incumbent whose cell-culture, transfection reagent, and cell-therapy portfolios compete for the same research budget. Often the default supplier for labs evaluating specialized transfection tooling.
• Lonza: Major CDMO and cell-therapy tools supplier, including the Nucleofector (now part of its bioscience portfolio) and other transfection/electroporation technologies. Comparable as a broad incumbent competing for the same cell-engineering workflow decisions.
• Polyplus (Sartorius): Provider of transfection reagents including PEI, lipid-based, and now LNP-related products, recently acquired by Sartorius. Competes with magnetofection as a non-viral delivery alternative for research and process development.
• STEMCELL Technologies: Major life-science tools company supplying cell-culture, differentiation, and engineering reagents to academic and translational researchers. Adjacent comparable because it sells complementary workflow products into the same research-lab customers that buy transfection tools.

Emerging players

• Mirus Bio (Gamma Biosciences): Specialist in non-viral transfection reagents (TransIT) for research and cell-therapy applications. Comparable as a focused non-viral delivery player serving an overlapping research-tools customer base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks6 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles5 records

Funding overview

Funding rounds2 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about nanoTherics